Transcriptional signature of cardiac myocyte recovery in mice and human reveals persistent upregulation of epigenetic factors

Fibrosis, cardiac remodelling, and inflammation are hallmarks of heart failure. To date, there is no available pharmacological cure for heart failure, but mechanical unloading by implantation of a left ventricular assist device (LVAD) can lead to improved cardiac function in a subset of patients. Th...

Full description

Saved in:
Bibliographic Details
Main Authors: Rebekka Roth, Margareta Häckh, Tilman Schnick, Carolin Rommel, Christoph Koentges, Heiko Bugger, Claudia Domisch, Michael R. Bristow, Amrut V. Ambardekar, Timothy A. McKinsey, Ralf Gilsbach, Lutz Hein, Sebastian Preissl
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Epigenetics
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/15592294.2025.2506625
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849723340942475264
author Rebekka Roth
Margareta Häckh
Tilman Schnick
Carolin Rommel
Christoph Koentges
Heiko Bugger
Claudia Domisch
Michael R. Bristow
Amrut V. Ambardekar
Timothy A. McKinsey
Ralf Gilsbach
Lutz Hein
Sebastian Preissl
author_facet Rebekka Roth
Margareta Häckh
Tilman Schnick
Carolin Rommel
Christoph Koentges
Heiko Bugger
Claudia Domisch
Michael R. Bristow
Amrut V. Ambardekar
Timothy A. McKinsey
Ralf Gilsbach
Lutz Hein
Sebastian Preissl
author_sort Rebekka Roth
collection DOAJ
description Fibrosis, cardiac remodelling, and inflammation are hallmarks of heart failure. To date, there is no available pharmacological cure for heart failure, but mechanical unloading by implantation of a left ventricular assist device (LVAD) can lead to improved cardiac function in a subset of patients. This study aimed to identify the transcriptional response of left ventricular (LV) cardiac myocytes to mechanical unloading in a mouse model of reversible LV pressure overload and in failing human hearts after LVAD implantation. We found that partial recovery of ventricular dysfunction, LV hypertrophy, and gene expression programmes occurred in mice under reversible transverse aortic constriction (rTAC). Gene expression analysis in cardiac myocytes identified a lasting repression of mitochondrial gene expression resulting in compromised fatty acid oxidation in the mouse model of reversible pressure overload and in human LV samples after LVAD therapy and a persistent upregulation of epigenetic and transcriptional regulators. These findings underpin that recovery from heart failure involves complex gene regulatory networks and that mitochondrial dysfunction remains a challenge even after mechanical unloading. Further studies are needed to investigate the functional role of these factors in reverse remodelling and recovery of failing hearts.
format Article
id doaj-art-d9636676ee984ce4bef2c72a6b881649
institution DOAJ
issn 1559-2294
1559-2308
language English
publishDate 2025-12-01
publisher Taylor & Francis Group
record_format Article
series Epigenetics
spelling doaj-art-d9636676ee984ce4bef2c72a6b8816492025-08-20T03:11:03ZengTaylor & Francis GroupEpigenetics1559-22941559-23082025-12-0120110.1080/15592294.2025.2506625Transcriptional signature of cardiac myocyte recovery in mice and human reveals persistent upregulation of epigenetic factorsRebekka Roth0Margareta Häckh1Tilman Schnick2Carolin Rommel3Christoph Koentges4Heiko Bugger5Claudia Domisch6Michael R. Bristow7Amrut V. Ambardekar8Timothy A. McKinsey9Ralf Gilsbach10Lutz Hein11Sebastian Preissl12Institute of Experimental and Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Freiburg, GermanyInstitute of Experimental and Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Freiburg, GermanyInstitute of Experimental and Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Freiburg, GermanyInstitute of Experimental and Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Freiburg, GermanyDepartment of Cardiology and Angiology, Faculty of Medicine, University Heart Center, University of Freiburg, GermanyDepartment of Cardiology and Angiology, Faculty of Medicine, University Heart Center, University of Freiburg, GermanyInstitute of Experimental and Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Freiburg, GermanyDepartment of Medicine, Division of Cardiology and Consortium for Fibrosis Research & Translation, University of Colorado Anschutz Medical Campus, Denver, CO, USADepartment of Medicine, Division of Cardiology and Consortium for Fibrosis Research & Translation, University of Colorado Anschutz Medical Campus, Denver, CO, USADepartment of Medicine, Division of Cardiology and Consortium for Fibrosis Research & Translation, University of Colorado Anschutz Medical Campus, Denver, CO, USAInstitute of Experimental Cardiology, Heidelberg University Hospital, Heidelberg, GermanyInstitute of Experimental and Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Freiburg, GermanyInstitute of Experimental and Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Freiburg, GermanyFibrosis, cardiac remodelling, and inflammation are hallmarks of heart failure. To date, there is no available pharmacological cure for heart failure, but mechanical unloading by implantation of a left ventricular assist device (LVAD) can lead to improved cardiac function in a subset of patients. This study aimed to identify the transcriptional response of left ventricular (LV) cardiac myocytes to mechanical unloading in a mouse model of reversible LV pressure overload and in failing human hearts after LVAD implantation. We found that partial recovery of ventricular dysfunction, LV hypertrophy, and gene expression programmes occurred in mice under reversible transverse aortic constriction (rTAC). Gene expression analysis in cardiac myocytes identified a lasting repression of mitochondrial gene expression resulting in compromised fatty acid oxidation in the mouse model of reversible pressure overload and in human LV samples after LVAD therapy and a persistent upregulation of epigenetic and transcriptional regulators. These findings underpin that recovery from heart failure involves complex gene regulatory networks and that mitochondrial dysfunction remains a challenge even after mechanical unloading. Further studies are needed to investigate the functional role of these factors in reverse remodelling and recovery of failing hearts.https://www.tandfonline.com/doi/10.1080/15592294.2025.2506625Heart failuremechanical unloadingreverse remodelingtranscriptomeepigeneticsmitochondria
spellingShingle Rebekka Roth
Margareta Häckh
Tilman Schnick
Carolin Rommel
Christoph Koentges
Heiko Bugger
Claudia Domisch
Michael R. Bristow
Amrut V. Ambardekar
Timothy A. McKinsey
Ralf Gilsbach
Lutz Hein
Sebastian Preissl
Transcriptional signature of cardiac myocyte recovery in mice and human reveals persistent upregulation of epigenetic factors
Epigenetics
Heart failure
mechanical unloading
reverse remodeling
transcriptome
epigenetics
mitochondria
title Transcriptional signature of cardiac myocyte recovery in mice and human reveals persistent upregulation of epigenetic factors
title_full Transcriptional signature of cardiac myocyte recovery in mice and human reveals persistent upregulation of epigenetic factors
title_fullStr Transcriptional signature of cardiac myocyte recovery in mice and human reveals persistent upregulation of epigenetic factors
title_full_unstemmed Transcriptional signature of cardiac myocyte recovery in mice and human reveals persistent upregulation of epigenetic factors
title_short Transcriptional signature of cardiac myocyte recovery in mice and human reveals persistent upregulation of epigenetic factors
title_sort transcriptional signature of cardiac myocyte recovery in mice and human reveals persistent upregulation of epigenetic factors
topic Heart failure
mechanical unloading
reverse remodeling
transcriptome
epigenetics
mitochondria
url https://www.tandfonline.com/doi/10.1080/15592294.2025.2506625
work_keys_str_mv AT rebekkaroth transcriptionalsignatureofcardiacmyocyterecoveryinmiceandhumanrevealspersistentupregulationofepigeneticfactors
AT margaretahackh transcriptionalsignatureofcardiacmyocyterecoveryinmiceandhumanrevealspersistentupregulationofepigeneticfactors
AT tilmanschnick transcriptionalsignatureofcardiacmyocyterecoveryinmiceandhumanrevealspersistentupregulationofepigeneticfactors
AT carolinrommel transcriptionalsignatureofcardiacmyocyterecoveryinmiceandhumanrevealspersistentupregulationofepigeneticfactors
AT christophkoentges transcriptionalsignatureofcardiacmyocyterecoveryinmiceandhumanrevealspersistentupregulationofepigeneticfactors
AT heikobugger transcriptionalsignatureofcardiacmyocyterecoveryinmiceandhumanrevealspersistentupregulationofepigeneticfactors
AT claudiadomisch transcriptionalsignatureofcardiacmyocyterecoveryinmiceandhumanrevealspersistentupregulationofepigeneticfactors
AT michaelrbristow transcriptionalsignatureofcardiacmyocyterecoveryinmiceandhumanrevealspersistentupregulationofepigeneticfactors
AT amrutvambardekar transcriptionalsignatureofcardiacmyocyterecoveryinmiceandhumanrevealspersistentupregulationofepigeneticfactors
AT timothyamckinsey transcriptionalsignatureofcardiacmyocyterecoveryinmiceandhumanrevealspersistentupregulationofepigeneticfactors
AT ralfgilsbach transcriptionalsignatureofcardiacmyocyterecoveryinmiceandhumanrevealspersistentupregulationofepigeneticfactors
AT lutzhein transcriptionalsignatureofcardiacmyocyterecoveryinmiceandhumanrevealspersistentupregulationofepigeneticfactors
AT sebastianpreissl transcriptionalsignatureofcardiacmyocyterecoveryinmiceandhumanrevealspersistentupregulationofepigeneticfactors